{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:42:42Z","timestamp":1792744962228,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcin.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:38:36Z","timestamp":1688999916000},"page":"1668-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent\u00a0Claudication"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-5606","authenticated-orcid":false,"given":"S. Elissa","family":"Altin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie N.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning A.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Creager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9061-7893","authenticated-orcid":false,"given":"Herbert D.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeptha P.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03187409","article-title":"Basic data related to the natural history of intermittent claudication","volume":"3","author":"McDaniel","year":"1989","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.jvs.2014.12.006","article-title":"Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jvs.2021.02.045","article-title":"Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates","volume":"74","author":"Madabhushi","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/S0002-9149(01)01671-X","article-title":"Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies","volume":"87","author":"Schmieder","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archsurg.1974.01360050087019","article-title":"Intermittent claudication. Surgical significance","volume":"109","author":"Peabody","year":"1974","journal-title":"Arch Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw057","article-title":"Long-term survival and fate of the leg in de novo intermittent claudication","volume":"3","author":"Kumakura","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jcin.2023.05.001_bib9","article-title":"The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study","volume":"8","author":"Rantner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcin.2023.05.001_bib10","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2023.05.001_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006564","article-title":"Drug-eluting versus bare-metal stent implantation with or without cilostazol in the treatment of the superficial femoral artery","volume":"11","author":"Miura","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","article-title":"Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial","volume":"8","author":"Garcia","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"Muller-Hulsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1526602818762805","article-title":"Full drug-eluting stent jacket: two-year results of a single-center experience with Zilver PTX stenting for long lesions in the femoropopliteal arteries","volume":"25","author":"Phillips","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-month results of the Lutonix Global SFA Registry: worldwide experience with Lutonix drug-coated balloon","volume":"10","author":"Thieme","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib25","first-page":"1259","article-title":"SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent","volume":"89","author":"Garcia","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.avsg.2016.08.006","article-title":"Real-world performance of paclitaxel drug-eluting bare metal stenting (Zilver PTX) for the treatment of femoropopliteal occlusive disease","volume":"38","author":"Tran","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib29","first-page":"130","article-title":"Real-world comparison of drug-eluting and bare-metal stents in superficial femoral artery occlusive disease with Trans-Atlantic Intersociety Consensus B lesions: a 2-year, single-institute study","volume":"34","author":"Meng","year":"2018","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jcin.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcin.2015.09.035","article-title":"Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 12-month results","volume":"9","author":"Yokoi","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00270-018-2110-1","article-title":"Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 2-year results","volume":"42","author":"Kichikawa","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1526602820966708","article-title":"Long-term effectiveness of a drug-eluting stent for femoropopliteal in-stent restenosis: subanalysis of the Zilver PTX Japan post-market surveillance study","volume":"28","author":"Sugimoto","year":"2021","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcin.2012.09.011","article-title":"Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry","volume":"6","author":"Scheinert","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jvir.2020.12.024","article-title":"Outcomes of drug-coated balloon angioplasty for isolated chronic occlusion of the popliteal artery: a retrospective single-institution study","volume":"32","author":"Wu","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1526602814564386","article-title":"Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial","volume":"22","author":"Rastan","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib38","first-page":"1","article-title":"Clinical outcomes and cost comparisons of stent and non-stent interventions in infrainguinal peripheral artery disease: insights from the Excellence in Peripheral Artery Disease (XLPAD) Registry","volume":"31","author":"Banerjee","year":"2019","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00270-020-02648-6","article-title":"Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX drug-eluting peripheral stent","volume":"44","author":"Dake","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1526602816650206","article-title":"Twelve-month results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease","volume":"23","author":"Muller-Hulsbeck","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12872-021-02127-x","article-title":"One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study","volume":"21","author":"Yu","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jcin.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejvs.2019.11.023","article-title":"Low risk of procedure related major amputation following revascularisation for intermittent claudication: a population based study","volume":"59","author":"Djerf","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.001_bib44","volume":"8","author":"Gunnarsson","year":"2020"},{"key":"10.1016\/j.jcin.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/1526602815608194","article-title":"Combined directional atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease","volume":"22","author":"Stavroulakis","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2023.05.001_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jvs.2021.07.106","article-title":"Critical appraisal of the contemporary use of atherectomy to treat femoropopliteal atherosclerotic disease","volume":"75","author":"Gupta","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1538574418772459","article-title":"High reintervention and amputation rates after outpatient atherectomy for claudication","volume":"52","author":"Mukherjee","year":"2018","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jcin.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.10765","article-title":"Risk of major amputation in patients with intermittent claudication undergoing early revascularization","volume":"105","author":"Golledge","year":"2018","journal-title":"Br J Surg"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823008208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823008208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:18:11Z","timestamp":1761848291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823008208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1936879823008208"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2023.05.001","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent\u00a0Claudication","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}